Drug Trial Radar · NCT02962414
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
206
Actual
Start
Aug 23, 2017
Primary completion
Feb 26, 2027
Study completion Feb 26, 2027
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Nov 11, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the long-term safety in patients with TSC and refractory seizures who are currently receiving everolimus treatment in the Novartis-sponsored EXIST-3 study and who are determined to be benefiting from continued treatment as judged by the investigator at the completion of EXIST-3
Conditions
- Tuberous Sclerosis Complex
Interventions
everolimusDrug
everolimus, 2mg dispersible tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Occurances of adverse events and serious adverse eventsTime frame: Day 1 up to approximately 10 years
Locations
68 sites in 18 countries. Site status is shown where the registry gives one.
TGen APNNA
Phoenix, Arizona
David Geffen School of Medicine at UCLA
Los Angeles, California
UCSF Benioff Children s Hospital
Oakland, California
Rady Children s Hospital
San Diego, California
University of Colorado School of Medicine
Aurora, Colorado
Connecticut Childrens Medical Cntr
Hartford, Connecticut
University of Chicago Medical Center
Chicago, Illinois
Minnesota Epilepsy Group
Saint Paul, Minnesota
Atlantic Health Morristown MC
Morristown, New Jersey
Cinn Children Hosp Medical Center
Cincinnati, Ohio
Oregon Health Sciences University
Portland, Oregon
Childrens Hospital of Philadelphia
Philadelphia, Pennsylvania
Texas Scottish Rite Hos for Child
Dallas, Texas
Texas Childrens Hospital
Houston, Texas
Novartis Investigative Site
Sydney, New South Wales, Australia
Novartis Investigative Site
Nedlands, Western Australia, Australia
Novartis Investigative Site
Brussels, Belgium
Novartis Investigative Site
Brussels, Belgium
Novartis Investigative Site
Ghent, Belgium
Novartis Investigative Site
Leuven, Belgium
Novartis Investigative Site
Vancouver, British Columbia, Canada
Novartis Investigative Site
Cali, Valle del Cauca Department, Colombia
Novartis Investigative Site
Amiens, France
Novartis Investigative Site
Bron, France
Novartis Investigative Site
Lille, France
Novartis Investigative Site
Marseille, France
Novartis Investigative Site
Strasbourg, France
Novartis Investigative Site
Budapest, Hungary
Novartis Investigative Site
Bari, BA, Italy
Novartis Investigative Site
Bologna, BO, Italy
Novartis Investigative Site
Pavia, PV, Italy
Novartis Investigative Site
Roma, RM, Italy
Novartis Investigative Site
Siena, SI, Italy
Novartis Investigative Site
Okayama, Japan
Novartis Investigative Site
Osaka, Osaka, Japan
Novartis Investigative Site
Suita, Osaka, Japan
Novartis Investigative Site
Shizuoka, Shizuoka, Japan
Novartis Investigative Site
Guadalajara, Jalisco, Mexico
Novartis Investigative Site
Warsaw, Poland
Novartis Investigative Site
Moscow, Russia
Showing 40 of 68 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.